Ideas to build
Build what Motir would buy.
A software company runs on more than code. It needs a lawyer, an accountant, a security team and people who know other markets, and Motir is no different. We would rather buy that work from a product built on Motir. These are the ones we need. Build one that scales, and Motir will be your first customer.
Motir is your first customer
Build one of these on Motir, in public, and we will use it, pay for it and tell you what is missing.
What makes a good idea here
Products that scale, not tools for one team
- Many customers, one productEvery idea serves thousands of companies with the same problem, not one company's own process.
- Expertise you can't hire cheaplyLaw, tax, security, languages: work that needs a specialist, made affordable by AI and kept honest by people.
- A person still signsThe AI drafts, checks and files the work. A qualified person approves what carries risk, the same way Motir puts a person at every gate.
Find an idea
5 ideas match
Tags · 1 selected
More directions · 5
Good products to build, beyond what Motir needs
Motir won't be your first customer for these. Each is a market with documented demand, a gap the current players leave open, and a reason it can be built now and not five years ago. The evidence is linked under each one.
Health & wellness
A brand-neutral companion for people on weight-loss pens in Brazil
For the millions of Brazilians on semaglutide or tirzepatide pens, now that cheaper Brazilian-made pens are reaching pharmacies. It keeps the prescription valid, tracks doses and side effects, guards against muscle loss, and compares prices across every brand's discount programme. Switching brands does not mean starting over.
- Consumers
- Healthcare
- Latin America market
- The evidence
- Anvisa approved 14 new pens for diabetes and obesity in 2026 (10 semaglutide, 3 liraglutide, 1 tirzepatide), including EMS's Ozivy (26 May) and products from Cosmed, Ávita Care, Brainfarma, Sun, Ranbaxy and Germed. Ozempic costs R$975 to R$999; Ozivy launched at R$452 to R$498 per pen; generics must be at least 35% cheaper than the reference drug. Revista Oeste (pt)
- The gap
- Support in Brazil is tied to one brand. Novo Nordisk's NovoDia and NovoCare cover only Novo products, EMS's Vida + Leve covers only Ozivy, and Eurofarma prices its own pens. A patient who switches to a cheaper pen leaves one programme and starts another. Clinic programmes such as Liti sell full medical follow-up at clinic prices. None keeps one record across brands that tracks the retained 90-day prescription, dose steps, side effects and protein in Portuguese.
Personal finance
Keep Medicaid and food benefits through the new work rules
For low-income adults who must now prove 80 hours a month of work, school or volunteering to keep Medicaid or SNAP: keeps a running monthly record, spots exemptions such as caregiving or illness, and answers the state's notices before the deadline.
- Consumers
- Healthcare
- The evidence
- CMS's interim final rule of 1 June 2026 sets an 80 hours per month work requirement for certain Medicaid adults. States must generally implement it no later than 1 January 2027, and a person found out of compliance gets 30 calendar days to show compliance or an exemption. CMS fact sheet, Medicaid community engagement interim final rule, June 2026
- The gap
- The tools sit on the institution's side. Fortuna Health reaches people through health systems and plans; Gainwell, Deloitte, Optum and Maximus sell verification systems to states; CMS's Emmy is state-hosted and piloting with one state; Propel serves SNAP balances. None keeps a person's own month-by-month record across gig work, school and volunteering, works out their exemption, and answers a notice in time.
Personal growth
A first tutor for young children
A voice tutor at home that teaches four-to-eight-year-olds to read, write and count, one child at a time, at the child's own pace.
- Consumers
- Education
- On YC's request list
- The evidence
- On Y Combinator's Fall 2026 Requests for Startups as "The Primer": a product that adaptively teaches young children to read, write, and do arithmetic. Y Combinator, Requests for Startups, Fall 2026
- The gap
- Ello, the funded AI tutor for this age, now teaches reading and maths at home but not writing, and the best-known AI tutors are built for schools, not homes.
Personal growth
A career coach for people who pay for themselves
Coaching and practice conversations for the job you want next, for the many workers whose employer won't pay for training.
- Consumers
- Education
- The evidence
- Valence raised a $50 million Series B for AI coaching after one million coaching conversations, showing AI coaching works when employers buy it. Valence, September 2025
- The gap
- AI coaching is sold mostly to employers, and learning platforms sell courses, not coaching. Consumer AI career coaches are only at seed stage, such as Blomma (more than $5M seed led by Felicis, April 2026), so the person who pays for themselves is barely served.
Family care
A care team app for families
Shares medicines, tasks and appointments across the family looking after a parent, and explains each care task in plain words.
- Caregiving
- Consumers
- Healthcare
- The evidence
- 63 million Americans, nearly 1 in 4 adults, are family caregivers, 20 million more than in 2015. More than half manage medical and nursing tasks, and just over 20% have had formal training. AARP and the National Alliance for Caregiving, July 2025
- The gap
- Care coordination is sold to employers as a benefit, comes with paid carers, or, like Hera ($27M Series A, June 2026), is run by nurse coordinators for Medicare patients. The free apps families use to share the work are basic.
Build one. We'll be your first customer.
Start with the idea, plan it with Motir and build it in public. Pick one of these, or bring your own.